Innorna

Innorna is a clinical-stage biotechnology company engineering mRNA-based medicines to treat chronic diseases, power in vivo immunotherapies, and prevent infectious diseases — improving lives worldwide.

Health and bio

Latest funding

Series B+ · April 1, 2022

Amount not disclosed in a source on record.

Funding history ↓

Website: innorna.com.

Category: Health and bio.

Stage: Series B+.

Last round: Apr 1, 2022 · 1,686 days ago.

On Recent Funding since: Nov 9, 2026.

Signals

Website registeredFeb 25, 2020 (6 years old)

Funding rounds

April 1, 2022
Series B+ · amount undisclosed
Source: fundraisingfox.com
February 25, 2020
Website created

Founders and team

LL
Linxian Li Co-founder | Chairman | CEO

source: innorna.com
CZ
Cindy Zhang Co-founder | Deputy General Manager

source: innorna.com

Companies like Innorna

AAsher Bio$55M Series B+ · Apr 2024
SStorm Therapeutics$56M Series B+ · Apr 2026
ZZag BioSeries A
TTiltbio$25M Series B+ · May 2025
EElevara$70M Series A · Oct 2025
GGilgamesh Pharmaceuticals$60M Series A · Mar 2026

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/innorna (get a free API key).